Despite the use of today’s preventive measures, VTE still happens. It’s still the monkey on your back.

For many post–orthopedic surgical patients, venous thromboembolism (VTE) poses a significant health risk. VTE consists of 2 potentially life–threatening conditions :
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)

These conditions can lead to long-term complications.

Learn about a treatment option for metastatic colorectal cancer and an initial treatment option for locally or regionally advanced head and neck cancer.

Colon Cancer:
ERBITUX (Cetuximab) is indicated for the treatment of patients who have colorectal cancer that has spread to other parts of the body and whose tumor expresses a protein called an Epidermal Growth Factor Receptor (EGFR).

Head & Neck Cancer:
ERBITUX (Cetuximab), in combination with radiation therapy, is indicated for the initial treatment of a certain type of locally or regionally advanced head and neck cancer.